The latest of the three vaccine candidates developed by U.S. government scientists to prevent African swine fever in pigs seems to show the most promise, those scientist say, but it might be years before any becomes commercially available. "This vaccine was 100 percent effective at a very low dose," said Douglas Gladue, a U.S. Department of Agriculture research microbiologist who developed the vaccine candidate with colleague Manuel Borca. "There was ...